UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Great Waters Wealth Management

Great Waters Wealth Management lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.2% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 18,634 shares of the healthcare conglomerate’s stock after selling 42 shares during the quarter. UnitedHealth Group makes up about 1.5% of Great Waters Wealth Management’s holdings, making the stock its 13th biggest position. Great Waters Wealth Management’s holdings in UnitedHealth Group were worth $9,218,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Richelieu Gestion SA purchased a new position in shares of UnitedHealth Group during the 4th quarter worth $26,000. CGC Financial Services LLC lifted its stake in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the period. True Wealth Design LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter worth $31,000. LFA Lugano Financial Advisors SA lifted its stake in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 40 shares during the period. Finally, Transcendent Capital Group LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter worth $40,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.7 %

Shares of UnitedHealth Group stock opened at $484.62 on Friday. The business has a 50-day moving average of $496.12 and a 200-day moving average of $504.71. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. The company has a market capitalization of $446.04 billion, a PE ratio of 29.62, a P/E/G ratio of 1.40 and a beta of 0.58. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter last year, the company posted $6.26 earnings per share. The company’s quarterly revenue was up 8.6% compared to the same quarter last year. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 27.57 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th will be given a dividend of $2.10 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date of this dividend is Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.73%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Wall Street Analyst Weigh In

UNH has been the topic of several research reports. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. TD Cowen cut their target price on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 target price on the stock in a research report on Wednesday, June 5th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research report on Wednesday, June 12th. Finally, Morgan Stanley lowered their price target on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Three research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $579.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.